Expert-Led Preclinical Support for Radiopharmaceutical Development

Whether you need full concept-to-IND guidance or a specific preclinical study, Adracco provides the expertise, infrastructure, and execution to move your program forward.

More Than Services, A Smarter Development Path.

Radiopharmaceutical developers often know they need preclinical data, but are not always certain which study should come first, how it should be designed, or what specific question the study needs to answer.

Working with Adracco means knowing you’ve defined the right development path before executing the work; building programs as a series of “next right steps” and ensuring each study supports a clear scientific and regulatory purpose.

Core Service Areas

  • Adracco helps teams determine the right sequence of preclinical work, align studies to development questions, and build a practical path toward IND readiness.

    • Preclinical development planning

    • Study design guidance

    • Development question framing

    • Concept-to-IND planning support

    • Go/no-go decision support

  • Adracco provides specialized scientific expertise and infrastructure to support the foundational work required for radiopharmaceutical development.

    • Radiolabeling support

    • Synthesis

    • Characterization

    • Candidate evaluation

    • Early feasibility work

  • Adracco supports key preclinical studies designed to help developers understand candidate behavior, performance, and development potential.

    • Biodistribution studies

    • Dynamic PET imaging

    • Mouse PET imaging

    • Imaging study execution

    • Data generation to support development decisions

  • Adracco helps teams generate the data and development clarity needed to move closer to IND readiness.

    • IND-oriented preclinical planning

    • Data generation strategy

    • Development-stage guidance

    • Support for investor, partner, and regulatory conversations; strong partner network including The Bracken Group for

Work With Us

Biodistribution Studies

-

PET Imaging (Dynamic & Mouse)

-

Imaging Study Execution

-

Data Generation

-

IND Preclinical Planning

-

Development-Stage Guidance

Biodistribution Studies - PET Imaging (Dynamic & Mouse) - Imaging Study Execution - Data Generation - IND Preclinical Planning - Development-Stage Guidance

Built Around the Support You Actually Need

Adracco offers targeted a la carte studies, broader packaged support, and full concept-to-IND guidance. This flexibility allows teams to access the right expertise and infrastructure without overbuilding too early or overcommitting before the development path is clear.

01
Targeted Study Support

Access individual capabilities as standalone engagements with full expert execution and deliverables: feasibility assessments, radiolabeling, biodistribution, PET/CT imaging, and therapy studies.

02
Starter Development Package

Combines feasibility assessment, candidate characterization, and radiolabeling feasibility into a structured starting point. Your first studies will answer the right questions from day one.

03
Concept-to-IND Guidance

Adracco maps the development sequence, executes the work, and builds toward IND readiness, covering early candidate evaluation through GMP synthesis and CMC documentation.

ADRACCO IS

The right-sized support for your team.

Adracco’s flexible model adapts to the needs of startups, medium-sized biotechs, and large pharma teams.

Not Sure What Study Comes Next?

Adracco can identify the right next step and design the preclinical work needed to move your program forward.

Talk To Our Team